Unicycive Therapeutics
Price & Volume
Stats
See moreOpen | $0.76 |
Previous Close | $0.77 |
Day Range | $0.71-$0.76 |
52W Range | $0.20-$1.81 |
Market Cap | $78.8M |
Shares Short | 989,174 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.46 |
News
See moreYahoo Finance • last year
Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023
Yahoo Finance • last year
Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)
Yahoo Finance • last year
Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD
About
CEO | Dr. Shalabh K. Gupta M.D., MPA |
Address | 4300 El Camino Real, Los Altos, CA, United States, 94022 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
